NeurAxis, Inc
NeurAxis, Inc. is dedicated to advancing neuromodulation therapies aimed at alleviating chronic and debilitating conditions, with a primary focus on pediatric and adolescent patients experiencing disorders related to gut-brain interactions. Their flagship product, IB-Stim, is a groundbreaking FDA-cleared device designed to address functional abdominal pain associated with irritable bowel syndrome in adolescents aged 8-21, providing a non-drug and non-surgical treatment option.
Committed to improving lives and minimizing suffering, NeurAxis continually evolves to meet the unmet healthcare needs of adults with gastrointestinal issues. Through innovative research and development, the company strives to reshape the future of patient care, enhancing outcomes for both children and the adults they will become.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
